CDK9-IN-2 is a special cyclin-dependent kinase 9 (CDK9) inhibitor, extracted from patent WO/2012131594A1, compound CDKI(8), has an IC50 of 5 nM and 7 nM in H929 multiple myeloma(MM) cell line (72 hours) and A2058 skin cell line (
Molecular Weight:
425.93
Purity:
>99%
CAS Number:
[1263369-28-3]
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted